A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

Clinical trial NCT06346600 · RECRUITING

Trial details

NCT number: NCT06346600
Sponsor: Skyline Therapeutics
Status: RECRUITING
Study type: OBSERVATIONAL

Neovascular (Wet) Age-related Macular Degeneration

Start date: 2024-04-02
Primary completion: 2031-03-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.